Literature DB >> 32474525

Use of contrast-enhanced ultrasound in evaluating the efficacy and application value of microwave ablation for adenomyosis.

Chao Xu1, Yanyan Tang2, Yingying Zhao3, Yongjie Li3, Qingliang Feng1.   

Abstract

AIM: This study aims to assess the use of contrast-enhanced ultrasonography (CEUS) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in the evaluation of percutaneous microwave ablation (PMWA) of localized adenomyosis.
MATERIALS AND METHODS: Sixty-six patients with single-onset adenomyosis who underwent PMWA at the Liaocheng Tumor Hospital of Shandong Province from January 2013 to February 2019 were enrolled. Venous CEUS and DCE-MRI examinations were performed before and 1-2 days after the surgery. The ablation rates calculated by CEUS and DCE-MRI were compared and analyzed for accuracy.
RESULTS: After microwave ablation (MWA), CEUS showed that the volume and ablation rate of the ablated zone were 52.03 ± 28.39 cm3 and 90.90% ±6.61%, respectively. By DCE-MRI, the ablation volume and ablation rate of adenomyosis were 52.20 ± 28.65 cm3 and 90.88% ±6.32%, respectively. Dysmenorrhea was significantly relieved within 3 months of the operation, and nonmenstrual hemoglobin levels were significantly improved at 3 and 6 months after the operation (P < 0.05). All 66 cases of adenomyosis were treated using PMWA. Postoperatively, 17 patients reported a change in vaginal fluid; however, no special treatment was required as this disappeared 2-11 days after surgery.
CONCLUSIONS: CEUS can accurately evaluate the ablation rate of localized adenomyosis treated with MWA, which is consistent with DCE-MRI. It is convenient and easy to perform ablation of adenomyomas, with incomplete ablation and angiography, and is a method worthy of clinical promotion.

Entities:  

Keywords:  Adenomyosis; contrast agent; magnetic resonance imaging; microwave ablation; ultrasound

Mesh:

Substances:

Year:  2020        PMID: 32474525     DOI: 10.4103/jcrt.JCRT_769_18

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  2 in total

1.  Contrast-Enhanced Ultrasound Imaging of Uterine Disorders: A Systematic Review.

Authors:  Barbara Stoelinga; Lynda Juffermans; Anniek Dooper; Marleen de Lange; Wouter Hehenkamp; Thierry Van den Bosch; Judith Huirne
Journal:  Ultrason Imaging       Date:  2021-05-26       Impact factor: 1.578

2.  Value of preoperative staging of endometrial carcinoma with contrast-enhanced ultrasonography: A PRISMA compliant meta-analysis.

Authors:  Xiaozhen Tong; Xiaofen Wu; Qiaohong Zhang
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.